Clonal expansion of p53 mutant cells is associated with brain tumour progression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-02

AUTHORS

David Sidransky, Tom Mikkelsen, Karl Schwechheimer, Mark L. Rosenblum, Web Cavanee, Bert Vogelstein

ABSTRACT

TUMOUR progression is a fundamental feature of the biology of cancer1. Cancers do not arise de novo in their final form, but begin as small, indolent growths, which gradually acquire characteristics associated with malignancy. In the brain, for example, low-grade tumours (astrocytomas) evolve into faster growing, more dysplastic and invasive high-grade tumours (glioblastomas)2,3. To define the genetic events underlying brain tumour progression, we analysed the p53 gene in ten primary brain tumour pairs. Seven pairs consisted of tumours that were high grade both at presentation and recurrence (group A) and three pairs consisted of low-grade tumours that had progressed to higher grade tumours (group B). In group A pairs, four of the recurrent tumours contained a p53 gene mutation; in three of them, the same mutation was found in the primary tumour. In group B pairs, progression to high grade was associated with a p53 gene mutation. A subpopulation of cells were present in the low-grade tumours that contained the same p53 gene mutation predominant in the cells of the recurrent tumours that had progressed to glioblastoma. Thus, the histological progression of brain tumours was associated with a clonal expansion of cells that had previously acquired a mutation in the p53 gene, endowing them with a selective growth advantage. These experimental observations strongly support Nowell's clonal evolution model of tumour progression4. More... »

PAGES

846-847

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/355846a0

DOI

http://dx.doi.org/10.1038/355846a0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024842732

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1311419


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Astrocytoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Base Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cloning, Molecular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, p53", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Sequence Data", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligodeoxyribonucleotides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sidransky", 
        "givenName": "David", 
        "id": "sg:person.01306437345.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306437345.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14709.3b", 
          "name": [
            "Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mikkelsen", 
        "givenName": "Tom", 
        "id": "sg:person.01331631345.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331631345.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abteilung Neuropatologi Pathologischer Institut, Albert Ludwigs Universitat, Frieberg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Abteilung Neuropatologi Pathologischer Institut, Albert Ludwigs Universitat, Frieberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwechheimer", 
        "givenName": "Karl", 
        "id": "sg:person.01256615337.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256615337.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brain Tumor Research Center, Department of Neurological Surgery, University of California Medical Center, 94143, San Francisco, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.413077.6", 
          "name": [
            "Brain Tumor Research Center, Department of Neurological Surgery, University of California Medical Center, 94143, San Francisco, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosenblum", 
        "givenName": "Mark L.", 
        "id": "sg:person.012346330132.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346330132.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14709.3b", 
          "name": [
            "Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavanee", 
        "givenName": "Web", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vogelstein", 
        "givenName": "Bert", 
        "id": "sg:person.011173760757.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011173760757.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/342705a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041126170", 
          "https://doi.org/10.1038/342705a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992-02", 
    "datePublishedReg": "1992-02-01", 
    "description": "TUMOUR progression is a fundamental feature of the biology of cancer1. Cancers do not arise de novo in their final form, but begin as small, indolent growths, which gradually acquire characteristics associated with malignancy. In the brain, for example, low-grade tumours (astrocytomas) evolve into faster growing, more dysplastic and invasive high-grade tumours (glioblastomas)2,3. To define the genetic events underlying brain tumour progression, we analysed the p53 gene in ten primary brain tumour pairs. Seven pairs consisted of tumours that were high grade both at presentation and recurrence (group A) and three pairs consisted of low-grade tumours that had progressed to higher grade tumours (group B). In group A pairs, four of the recurrent tumours contained a p53 gene mutation; in three of them, the same mutation was found in the primary tumour. In group B pairs, progression to high grade was associated with a p53 gene mutation. A subpopulation of cells were present in the low-grade tumours that contained the same p53 gene mutation predominant in the cells of the recurrent tumours that had progressed to glioblastoma. Thus, the histological progression of brain tumours was associated with a clonal expansion of cells that had previously acquired a mutation in the p53 gene, endowing them with a selective growth advantage. These experimental observations strongly support Nowell's clonal evolution model of tumour progression4.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/355846a0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6363", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "355"
      }
    ], 
    "keywords": [
      "low-grade tumors", 
      "p53 gene mutations", 
      "high-grade tumors", 
      "brain tumor progression", 
      "tumor progression", 
      "recurrent tumors", 
      "gene mutations", 
      "invasive high-grade tumours", 
      "same p53 gene mutation", 
      "clonal expansion", 
      "p53 gene", 
      "high grade", 
      "clonal evolution model", 
      "indolent growth", 
      "histological progression", 
      "grade tumors", 
      "primary tumor", 
      "p53 mutant cells", 
      "brain tumors", 
      "subpopulation of cells", 
      "tumors", 
      "progression", 
      "tumor pairs", 
      "selective growth advantage", 
      "same mutation", 
      "genetic events", 
      "cells", 
      "growth advantage", 
      "de novo", 
      "mutations", 
      "grade", 
      "malignancy", 
      "recurrence", 
      "cancer", 
      "brain", 
      "cancer1", 
      "subpopulations", 
      "presentation", 
      "genes", 
      "novo", 
      "mutant cells", 
      "events", 
      "biology", 
      "features", 
      "growth", 
      "characteristics", 
      "expansion", 
      "observations", 
      "fundamental features", 
      "form", 
      "pairs", 
      "model", 
      "advantages", 
      "final form", 
      "example", 
      "experimental observations", 
      "evolution model"
    ], 
    "name": "Clonal expansion of p53 mutant cells is associated with brain tumour progression", 
    "pagination": "846-847", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024842732"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/355846a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1311419"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/355846a0", 
      "https://app.dimensions.ai/details/publication/pub.1024842732"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T09:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_235.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/355846a0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/355846a0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/355846a0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/355846a0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/355846a0'


 

This table displays all metadata directly associated to this object as RDF triples.

218 TRIPLES      22 PREDICATES      98 URIs      89 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/355846a0 schema:about N140b095d6f514093a7addacea0f5a5e5
2 N30294f02581749b688c6a976c1bf2f74
3 N362fb78fe364481d8c19a1da2e3f106e
4 N3d0ad33d9eb3489c924254b499c50856
5 N4320cb74d9a448a2b8a8c713a6d15658
6 N6a9955709e8443a4b8c31e1d53ec8d8f
7 N7762bba6692d4915b6e3cf8b6ac8b2b9
8 N86bea6f015754ef4958884c5b362f8f4
9 Na0aba79ab6bb4071a95001713ea81888
10 Na37b36673278425991ea41e35fd28f23
11 Na8aa1dfda5bc4913b422dc1d33f482e2
12 Nd915e94514084cbf873477ba4fb87fbe
13 Nfc5daf3e4d7143ccba8334db2e983fa9
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Na500e9a03953480287cea398fe56e6ba
17 schema:citation sg:pub.10.1038/342705a0
18 schema:datePublished 1992-02
19 schema:datePublishedReg 1992-02-01
20 schema:description TUMOUR progression is a fundamental feature of the biology of cancer1. Cancers do not arise de novo in their final form, but begin as small, indolent growths, which gradually acquire characteristics associated with malignancy. In the brain, for example, low-grade tumours (astrocytomas) evolve into faster growing, more dysplastic and invasive high-grade tumours (glioblastomas)2,3. To define the genetic events underlying brain tumour progression, we analysed the p53 gene in ten primary brain tumour pairs. Seven pairs consisted of tumours that were high grade both at presentation and recurrence (group A) and three pairs consisted of low-grade tumours that had progressed to higher grade tumours (group B). In group A pairs, four of the recurrent tumours contained a p53 gene mutation; in three of them, the same mutation was found in the primary tumour. In group B pairs, progression to high grade was associated with a p53 gene mutation. A subpopulation of cells were present in the low-grade tumours that contained the same p53 gene mutation predominant in the cells of the recurrent tumours that had progressed to glioblastoma. Thus, the histological progression of brain tumours was associated with a clonal expansion of cells that had previously acquired a mutation in the p53 gene, endowing them with a selective growth advantage. These experimental observations strongly support Nowell's clonal evolution model of tumour progression4.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N7b32dd300a10442bb5141201f7d4a593
25 Nc88499809a6a49c88fd46684de53ea73
26 sg:journal.1018957
27 schema:keywords advantages
28 biology
29 brain
30 brain tumor progression
31 brain tumors
32 cancer
33 cancer1
34 cells
35 characteristics
36 clonal evolution model
37 clonal expansion
38 de novo
39 events
40 evolution model
41 example
42 expansion
43 experimental observations
44 features
45 final form
46 form
47 fundamental features
48 gene mutations
49 genes
50 genetic events
51 grade
52 grade tumors
53 growth
54 growth advantage
55 high grade
56 high-grade tumors
57 histological progression
58 indolent growth
59 invasive high-grade tumours
60 low-grade tumors
61 malignancy
62 model
63 mutant cells
64 mutations
65 novo
66 observations
67 p53 gene
68 p53 gene mutations
69 p53 mutant cells
70 pairs
71 presentation
72 primary tumor
73 progression
74 recurrence
75 recurrent tumors
76 same mutation
77 same p53 gene mutation
78 selective growth advantage
79 subpopulation of cells
80 subpopulations
81 tumor pairs
82 tumor progression
83 tumors
84 schema:name Clonal expansion of p53 mutant cells is associated with brain tumour progression
85 schema:pagination 846-847
86 schema:productId N1fdc07af239645709b3bb2cd5a4f5fe3
87 N676ebcc4cb81441ab8444d55760ce8e1
88 Ne61153ab726e44eea68e227a9bd4b7d7
89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024842732
90 https://doi.org/10.1038/355846a0
91 schema:sdDatePublished 2022-05-10T09:45
92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
93 schema:sdPublisher Nef57bedac7c84cdeb4919afd29fea43b
94 schema:url https://doi.org/10.1038/355846a0
95 sgo:license sg:explorer/license/
96 sgo:sdDataset articles
97 rdf:type schema:ScholarlyArticle
98 N12babbb353654a87b7ab684d768ff984 rdf:first sg:person.01256615337.43
99 rdf:rest Ne2f9cbb3249245318276f344ad1d6e0b
100 N13f11f33415649fd9a75f7a3dc8c34ee rdf:first sg:person.01331631345.87
101 rdf:rest N12babbb353654a87b7ab684d768ff984
102 N140b095d6f514093a7addacea0f5a5e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Astrocytoma
104 rdf:type schema:DefinedTerm
105 N1fdc07af239645709b3bb2cd5a4f5fe3 schema:name pubmed_id
106 schema:value 1311419
107 rdf:type schema:PropertyValue
108 N30294f02581749b688c6a976c1bf2f74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Amino Acid Sequence
110 rdf:type schema:DefinedTerm
111 N362fb78fe364481d8c19a1da2e3f106e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Tumor Suppressor Protein p53
113 rdf:type schema:DefinedTerm
114 N3d0ad33d9eb3489c924254b499c50856 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Polymerase Chain Reaction
116 rdf:type schema:DefinedTerm
117 N4320cb74d9a448a2b8a8c713a6d15658 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Base Sequence
119 rdf:type schema:DefinedTerm
120 N676ebcc4cb81441ab8444d55760ce8e1 schema:name doi
121 schema:value 10.1038/355846a0
122 rdf:type schema:PropertyValue
123 N6a9955709e8443a4b8c31e1d53ec8d8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cloning, Molecular
125 rdf:type schema:DefinedTerm
126 N7762bba6692d4915b6e3cf8b6ac8b2b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Brain Neoplasms
128 rdf:type schema:DefinedTerm
129 N7b32dd300a10442bb5141201f7d4a593 schema:volumeNumber 355
130 rdf:type schema:PublicationVolume
131 N86bea6f015754ef4958884c5b362f8f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Glioblastoma
133 rdf:type schema:DefinedTerm
134 N891852302af64819a2baa0ec3120efd9 rdf:first N8aa49194763c4359ba1f7f6ff94276c6
135 rdf:rest Nbc9023d9d77847a9a0af020e5c6db203
136 N8aa49194763c4359ba1f7f6ff94276c6 schema:affiliation grid-institutes:grid.14709.3b
137 schema:familyName Cavanee
138 schema:givenName Web
139 rdf:type schema:Person
140 Na0aba79ab6bb4071a95001713ea81888 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Genes, p53
142 rdf:type schema:DefinedTerm
143 Na37b36673278425991ea41e35fd28f23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Molecular Sequence Data
145 rdf:type schema:DefinedTerm
146 Na500e9a03953480287cea398fe56e6ba rdf:first sg:person.01306437345.76
147 rdf:rest N13f11f33415649fd9a75f7a3dc8c34ee
148 Na8aa1dfda5bc4913b422dc1d33f482e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Mitosis
150 rdf:type schema:DefinedTerm
151 Nbc9023d9d77847a9a0af020e5c6db203 rdf:first sg:person.011173760757.54
152 rdf:rest rdf:nil
153 Nc88499809a6a49c88fd46684de53ea73 schema:issueNumber 6363
154 rdf:type schema:PublicationIssue
155 Nd915e94514084cbf873477ba4fb87fbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 Ne2f9cbb3249245318276f344ad1d6e0b rdf:first sg:person.012346330132.20
159 rdf:rest N891852302af64819a2baa0ec3120efd9
160 Ne61153ab726e44eea68e227a9bd4b7d7 schema:name dimensions_id
161 schema:value pub.1024842732
162 rdf:type schema:PropertyValue
163 Nef57bedac7c84cdeb4919afd29fea43b schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nfc5daf3e4d7143ccba8334db2e983fa9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Oligodeoxyribonucleotides
167 rdf:type schema:DefinedTerm
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
172 schema:name Oncology and Carcinogenesis
173 rdf:type schema:DefinedTerm
174 sg:journal.1018957 schema:issn 0028-0836
175 1476-4687
176 schema:name Nature
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.011173760757.54 schema:affiliation grid-institutes:grid.21107.35
180 schema:familyName Vogelstein
181 schema:givenName Bert
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011173760757.54
183 rdf:type schema:Person
184 sg:person.012346330132.20 schema:affiliation grid-institutes:grid.413077.6
185 schema:familyName Rosenblum
186 schema:givenName Mark L.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346330132.20
188 rdf:type schema:Person
189 sg:person.01256615337.43 schema:affiliation grid-institutes:None
190 schema:familyName Schwechheimer
191 schema:givenName Karl
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256615337.43
193 rdf:type schema:Person
194 sg:person.01306437345.76 schema:affiliation grid-institutes:grid.21107.35
195 schema:familyName Sidransky
196 schema:givenName David
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306437345.76
198 rdf:type schema:Person
199 sg:person.01331631345.87 schema:affiliation grid-institutes:grid.14709.3b
200 schema:familyName Mikkelsen
201 schema:givenName Tom
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331631345.87
203 rdf:type schema:Person
204 sg:pub.10.1038/342705a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041126170
205 https://doi.org/10.1038/342705a0
206 rdf:type schema:CreativeWork
207 grid-institutes:None schema:alternateName Abteilung Neuropatologi Pathologischer Institut, Albert Ludwigs Universitat, Frieberg, Germany
208 schema:name Abteilung Neuropatologi Pathologischer Institut, Albert Ludwigs Universitat, Frieberg, Germany
209 rdf:type schema:Organization
210 grid-institutes:grid.14709.3b schema:alternateName Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada
211 schema:name Ludwig Institute for Cancer Research, H3A 1A1, Montreal, Province of Quebec, Canada
212 rdf:type schema:Organization
213 grid-institutes:grid.21107.35 schema:alternateName The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA
214 schema:name The Department of Oncology, The Johns Hopkins University School of Medicine, 21231, Baltimore, Maryland, USA
215 rdf:type schema:Organization
216 grid-institutes:grid.413077.6 schema:alternateName Brain Tumor Research Center, Department of Neurological Surgery, University of California Medical Center, 94143, San Francisco, California, USA
217 schema:name Brain Tumor Research Center, Department of Neurological Surgery, University of California Medical Center, 94143, San Francisco, California, USA
218 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...